CA2093429A1 - Methode de biophosphorylation des composes organiques - Google Patents
Methode de biophosphorylation des composes organiquesInfo
- Publication number
- CA2093429A1 CA2093429A1 CA002093429A CA2093429A CA2093429A1 CA 2093429 A1 CA2093429 A1 CA 2093429A1 CA 002093429 A CA002093429 A CA 002093429A CA 2093429 A CA2093429 A CA 2093429A CA 2093429 A1 CA2093429 A1 CA 2093429A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- phosphorylated
- pct
- hydroxy
- macrolide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65525—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a seven-(or more) membered ring
- C07F9/65527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a seven-(or more) membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59450090A | 1990-10-09 | 1990-10-09 | |
| US59421490A | 1990-10-09 | 1990-10-09 | |
| US07/594,214 | 1990-10-09 | ||
| US07/594,500 | 1990-10-09 | ||
| US59589490A | 1990-10-11 | 1990-10-11 | |
| US07/595,894 | 1990-10-11 | ||
| US69160791A | 1991-04-26 | 1991-04-26 | |
| US07/691,606 | 1991-04-26 | ||
| US07/691,606 US5198421A (en) | 1991-04-26 | 1991-04-26 | Phosphorylated cyclic lipopeptide |
| US07/691,607 | 1991-04-26 | ||
| US70138791A | 1991-05-16 | 1991-05-16 | |
| US07/701,387 | 1991-05-16 | ||
| US73596391A | 1991-07-25 | 1991-07-25 | |
| US07/735,963 | 1991-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2093429A1 true CA2093429A1 (fr) | 1992-04-10 |
Family
ID=27569847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002093429A Abandoned CA2093429A1 (fr) | 1990-10-09 | 1991-09-19 | Methode de biophosphorylation des composes organiques |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0552309A1 (fr) |
| JP (1) | JPH06502536A (fr) |
| CA (1) | CA2093429A1 (fr) |
| WO (1) | WO1992006992A2 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5493107A (en) * | 1993-05-07 | 1996-02-20 | Digicomp Research Corporation | Shelf price label and product placement verification method and apparatus |
| ES2065290B1 (es) * | 1993-07-29 | 1995-11-01 | Consejo Superior Investigacion | Utilizacion de inhibidores enzimaticos para el tratamiento de enfermedades causadas por parasitos. |
| DK0864653T3 (da) * | 1997-03-11 | 2004-07-12 | Aventis Pharma Inc | Fremgangsmåde til fremstilling af 4-(4-(4-(hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alfa,alfa-dimethylphenyleddikesyre og phosphorylerede derivater deraf |
| BR0307544A (pt) | 2002-02-01 | 2004-12-07 | Ariad Gene Therapeutics Inc | Compostos contendo fósforos, componentes e composição bem como, sua utilização através de métodos de tratamentos |
| AU2003901812A0 (en) * | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphates of secondary alcohols |
| DE102005056669A1 (de) | 2005-11-28 | 2007-05-31 | Basf Ag | Fermentative Herstellung organischer Verbindungen unter Einsatz Dextrin-haltiger Medien |
| CA2669415A1 (fr) | 2006-11-14 | 2008-05-22 | Ariad Pharmaceuticals, Inc. | Formulations orales |
| EP3019461A1 (fr) * | 2013-08-19 | 2016-05-18 | REG Life Sciences, LLC | Production de glycérol résiduaire partiellement raffiné |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61172888A (ja) * | 1985-01-29 | 1986-08-04 | Asahi Denka Kogyo Kk | 有機リン酸化合物金属塩およびこれを含有する高脂血症治療剤 |
| IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
| IL94862A (en) * | 1989-06-30 | 1994-10-07 | Merck & Co Inc | History of Echinocandin Antifungal Antibiotics, Its Production and Pharmaceutical Preparations Containing It |
| CA2032259A1 (fr) * | 1989-12-18 | 1991-06-19 | Wayne J. Thompson | Inhibiteurs de la protease du vih utiles dans le traitement du sida |
-
1991
- 1991-09-19 WO PCT/US1991/006816 patent/WO1992006992A2/fr not_active Ceased
- 1991-09-19 CA CA002093429A patent/CA2093429A1/fr not_active Abandoned
- 1991-09-19 EP EP92901105A patent/EP0552309A1/fr not_active Withdrawn
- 1991-09-19 JP JP4501234A patent/JPH06502536A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992006992A2 (fr) | 1992-04-30 |
| JPH06502536A (ja) | 1994-03-24 |
| EP0552309A1 (fr) | 1993-07-28 |
| WO1992006992A3 (fr) | 1992-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0349061B1 (fr) | Agent immuno-suppresseur | |
| US4981792A (en) | Immunosuppressant compound | |
| JP3039780B2 (ja) | 免疫抑制剤の生産法 | |
| EP0388153B1 (fr) | Agent immunosuppressif | |
| US4987139A (en) | FK-520 microbial transformation product | |
| US5198421A (en) | Phosphorylated cyclic lipopeptide | |
| CA2020062C (fr) | Agent antibiotique | |
| US5233023A (en) | Process for phosphate ester compounds of certain cyclohexapeptides | |
| US4975372A (en) | Microbial transformation product of L-683,590 | |
| EP0358508A2 (fr) | Composé immunosuppreseur | |
| WO1992006992A2 (fr) | Nouveau procede pour biophosphoryler des composes organiques | |
| CA2038495A1 (fr) | Agents antibiotiques | |
| EP0323865A1 (fr) | Agent immunopresseur | |
| RU2266911C2 (ru) | Циклипостины, способ их получения, фармацевтическая композиция на их основе, способ ее получения и штамм streptjmyces, являющийся продуцентом циклипостинов | |
| EP0466365A2 (fr) | Produits d'une fermentation d'un micro-organisme ayant une activité immunosupressante | |
| US5290772A (en) | Immunosuppressant agent | |
| EP0396400A1 (fr) | Produit microbien de transformation | |
| US5252612A (en) | Microbial immunosoppressant agent | |
| US5268370A (en) | Microbial transformation product of L-679,934 | |
| EP0378317A2 (fr) | Produit de transformation microbienne L-679,934 | |
| EP0378320A2 (fr) | Produit de transformation microbienne | |
| US5270187A (en) | Microbial transformation product | |
| EP0452683A2 (fr) | Substance antitumorale de streptomyces et son procédé de préparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |